The ground-breaking technology analyses blood sugar levels to maintain consistent levels of blood sugar and utilises an algorithm to calculate how much insulin should be supplied. A ground-breaking NHS experiment revealed that it required significantly less user input than existing devices and was more successful at managing diabetes.
A system of three components known as an artificial pancreas functions to imitate how a healthy pancreas regulates blood glucose, also known as blood sugar, in the body. The majority of those who benefit from an artificial pancreas have type 1 diabetes.
The Artificial Pancreas Device System does not produce insulin in people with type 1 diabetes. People with type 1 diabetes manage their blood glucose levels by monitoring them and administering insulin many times per day by injection or insulin infusion pump. Your blood glucose level is automatically tracked by an artificial pancreas, which also determines how much insulin you'll need during the day and administers it.
The majority of artificial pancreas systems demand that you count and input how many carbohydrates you ingest each meal. A tiny sensor that is implanted under the skin serves as the basis of a continuous glucose monitor (CGM), which measures blood glucose levels every few minutes. The sensor wirelessly transmits the data to a smartphone app or an insulin infusion pump programme.
The computer programme determines how much insulin is required and alerts the insulin infusion pump when it is time to start giving insulin. When blood glucose levels are outside of your desired range, the insulin infusion pump will slowly release modest doses of insulin throughout the day. Different insulin pumps come in various varieties.
Read More:
https://cmihelloglow.blogspot.com/2023/05/the-features-of-diabetes-management.html
The global artificial pancreas device system market size is expected to value USD 390.4 million by 2024, during the forecast period.
The artificial pancreas device system industry is subject to witness a substantial growth due to growing occurrence of heart-related diseases such as diabetes, extensive research and development efforts by market players, and growing need for advanced electronic systems in healthcare sector such as glycemic control.
Artificial pancreas device system allows easy monitoring of the blood-glucose level in case of facilitates diabetes management.
Globally, the artificial pancreas device system market is predicted to grow at a CAGR of 20.2% in forecast period, providing numerous opportunities for market players to invest in research and development.
Download Free Sample Report @ https://www.millioninsights.com/industry-reports/artificial-pancreas-device-system-apds-market/request-sample The growing occurrence of diabetes in both - developing and developed economies is attributed to changing food patterns, inherited diseases, obesity, physical inactivity and high calorie diet, all leading to the growth of the artificial pancreas device system industry in recent years.
Though, unavailability of highly skilled healthcare professionals in underdeveloped countries in African and South American regions is likely to hamper the growth of the market.
